Literature DB >> 3966957

Successful treatment of atrial tachycardias with flecainide acetate.

J E Creamer, A W Nathan, A J Camm.   

Abstract

Intravenous flecainide successfully terminated atrial tachycardia in three patients. Maintenance treatment with oral flecainide prevented the recurrence of tachycardia for up to three years. These results suggest an additional use for flecainide which should be further explored.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3966957      PMCID： PMC481734          DOI： 10.1136/hrt.53.2.164

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  8 in total

1.  Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification.

Authors:  T J Campbell
Journal:  Cardiovasc Res       Date:  1983-06       Impact factor: 10.787

2.  Antiarrhythmic and hemodynamic actions of flecainide acetate (R-818) in the ischemic porcine heart.

Authors:  P D Verdouw; J W Deckers; G J Conrad
Journal:  J Cardiovasc Pharmacol       Date:  1979 Jul-Aug       Impact factor: 3.105

3.  Effect of intravenous flecainide on atrial vulnerability in man.

Authors:  T Pop; N Treese; J C Kang; T Meinertz; W Kasper
Journal:  Klin Wochenschr       Date:  1983-06-15

4.  Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.

Authors:  K J Hellestrand; A W Nathan; R S Bexton; R A Spurrell; A J Camm
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

5.  Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.

Authors:  K J Hellestrand; R S Bexton; A W Nathan; R A Spurrell; A J Camm
Journal:  Br Heart J       Date:  1982-08

6.  Antiarrhythmic effects of flecainide.

Authors:  P Somani
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

7.  Oral flecainide acetate for the treatment of ventricular arrhythmias.

Authors:  J L Anderson; J R Stewart; B A Perry; D D Van Hamersveld; T A Johnson; G J Conard; S F Chang; D C Kvam; B Pitt
Journal:  N Engl J Med       Date:  1981-08-27       Impact factor: 91.245

8.  Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.

Authors:  M Hodges; J M Haugland; G Granrud; G J Conard; R W Asinger; F L Mikell; J Krejci
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690
  8 in total
  4 in total

1.  Pseudocardiomyopathy secondary to chronic incessant supraventricular tachycardia.

Authors:  G Gladman; J L Wilkinson; G Evans-Jones
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

2.  Encainide versus flecainide in the treatment of chronic resistant paroxysmal atrial tachyarrhythmias.

Authors:  P Coumel
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

3.  Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.

Authors:  A J Camm; K J Hellestrand; A W Nathan; R S Bexton
Journal:  Drugs       Date:  1985       Impact factor: 9.546

4.  Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass.

Authors:  T P Gavaghan; A M Koegh; R P Kelly; T J Campbell; C Thorburn; J J Morgan
Journal:  Br Heart J       Date:  1988-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.